Cargando…

Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats

Diabetes mellitus causes secondary osteoporosis and muscle atrophy. The ability of alfacalcidol (ALF) and exercise (Exe) to inhibit osteoporosis and muscle atrophy in type 2 diabetes mellitus (T2DM) model rats was examined. Twenty-week-old Otsuka Long-Evans Tokushima Fatty rats were randomized to AL...

Descripción completa

Detalles Bibliográficos
Autores principales: Akagawa, Manabu, Miyakoshi, Naohisa, Kasukawa, Yuji, Ono, Yuichi, Yuasa, Yusuke, Nagahata, Itsuki, Sato, Chiaki, Tsuchie, Hiroyuki, Nagasawa, Hiroyuki, Hongo, Michio, Shimada, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192580/
https://www.ncbi.nlm.nih.gov/pubmed/30332436
http://dx.doi.org/10.1371/journal.pone.0204857
_version_ 1783363925227601920
author Akagawa, Manabu
Miyakoshi, Naohisa
Kasukawa, Yuji
Ono, Yuichi
Yuasa, Yusuke
Nagahata, Itsuki
Sato, Chiaki
Tsuchie, Hiroyuki
Nagasawa, Hiroyuki
Hongo, Michio
Shimada, Yoichi
author_facet Akagawa, Manabu
Miyakoshi, Naohisa
Kasukawa, Yuji
Ono, Yuichi
Yuasa, Yusuke
Nagahata, Itsuki
Sato, Chiaki
Tsuchie, Hiroyuki
Nagasawa, Hiroyuki
Hongo, Michio
Shimada, Yoichi
author_sort Akagawa, Manabu
collection PubMed
description Diabetes mellitus causes secondary osteoporosis and muscle atrophy. The ability of alfacalcidol (ALF) and exercise (Exe) to inhibit osteoporosis and muscle atrophy in type 2 diabetes mellitus (T2DM) model rats was examined. Twenty-week-old Otsuka Long-Evans Tokushima Fatty rats were randomized to ALF (orally 0.1 μg/kg/day), Exe (treadmill exercise at 10 m/min, 60 min/day, 5 days/week), Comb (ALF and Exe), and Cont (T2DM control treated with vehicle and no exercise) groups (n = 8–10 per group). Sedentary Long-Evans Tokushima Otsuka rats were used as a non-hyperphagic control. After treatment for 2 or 6 weeks, blood glucose (BG) levels, cross-sectional area (CSA) of tibialis anterior muscle fibers, femoral bone mineral density (BMD), and relative quantities of muscle anabolic markers (Pax7, MyoD, and myogenin) and catabolic markers (Atrogin-1, MuRF1, and REDD1) of the soleus muscle assessed by real-time polymerase chain reaction assays were measured. Exe and Comb treatments for 6 weeks decreased BG levels compared with those of the Cont group. ALF, Exe, and Comb treatments for 2 and 6 weeks recovered the CSA compared with that of the Cont group. ALF and Comb treatments for 6 weeks increased femoral BMDs compared with those of the Cont group. After 2 weeks of treatment, Comb treatment increased MyoD expression and decreased MuRF1 expression. ALF or Exe monotherapy significantly decreased Atrogin-1 or MuRF1 expression after 2 weeks of treatment, respectively. After 6 weeks of treatment, ALF and Comb treatments decreased Atrogin-1 and REDD1. These results demonstrate that a combination of ALF and Exe improved CSA from the early phase of treatment by stimulating skeletal muscle differentiation and suppressing muscle catabolic genes. Improvements in BG, BMD, and CSA were observed as long-term effects of the combination therapy. Continued suppression of muscle catabolic genes was observed as a background to these effects.
format Online
Article
Text
id pubmed-6192580
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-61925802018-11-05 Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats Akagawa, Manabu Miyakoshi, Naohisa Kasukawa, Yuji Ono, Yuichi Yuasa, Yusuke Nagahata, Itsuki Sato, Chiaki Tsuchie, Hiroyuki Nagasawa, Hiroyuki Hongo, Michio Shimada, Yoichi PLoS One Research Article Diabetes mellitus causes secondary osteoporosis and muscle atrophy. The ability of alfacalcidol (ALF) and exercise (Exe) to inhibit osteoporosis and muscle atrophy in type 2 diabetes mellitus (T2DM) model rats was examined. Twenty-week-old Otsuka Long-Evans Tokushima Fatty rats were randomized to ALF (orally 0.1 μg/kg/day), Exe (treadmill exercise at 10 m/min, 60 min/day, 5 days/week), Comb (ALF and Exe), and Cont (T2DM control treated with vehicle and no exercise) groups (n = 8–10 per group). Sedentary Long-Evans Tokushima Otsuka rats were used as a non-hyperphagic control. After treatment for 2 or 6 weeks, blood glucose (BG) levels, cross-sectional area (CSA) of tibialis anterior muscle fibers, femoral bone mineral density (BMD), and relative quantities of muscle anabolic markers (Pax7, MyoD, and myogenin) and catabolic markers (Atrogin-1, MuRF1, and REDD1) of the soleus muscle assessed by real-time polymerase chain reaction assays were measured. Exe and Comb treatments for 6 weeks decreased BG levels compared with those of the Cont group. ALF, Exe, and Comb treatments for 2 and 6 weeks recovered the CSA compared with that of the Cont group. ALF and Comb treatments for 6 weeks increased femoral BMDs compared with those of the Cont group. After 2 weeks of treatment, Comb treatment increased MyoD expression and decreased MuRF1 expression. ALF or Exe monotherapy significantly decreased Atrogin-1 or MuRF1 expression after 2 weeks of treatment, respectively. After 6 weeks of treatment, ALF and Comb treatments decreased Atrogin-1 and REDD1. These results demonstrate that a combination of ALF and Exe improved CSA from the early phase of treatment by stimulating skeletal muscle differentiation and suppressing muscle catabolic genes. Improvements in BG, BMD, and CSA were observed as long-term effects of the combination therapy. Continued suppression of muscle catabolic genes was observed as a background to these effects. Public Library of Science 2018-10-17 /pmc/articles/PMC6192580/ /pubmed/30332436 http://dx.doi.org/10.1371/journal.pone.0204857 Text en © 2018 Akagawa et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Akagawa, Manabu
Miyakoshi, Naohisa
Kasukawa, Yuji
Ono, Yuichi
Yuasa, Yusuke
Nagahata, Itsuki
Sato, Chiaki
Tsuchie, Hiroyuki
Nagasawa, Hiroyuki
Hongo, Michio
Shimada, Yoichi
Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats
title Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats
title_full Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats
title_fullStr Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats
title_full_unstemmed Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats
title_short Effects of activated vitamin D, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats
title_sort effects of activated vitamin d, alfacalcidol, and low-intensity aerobic exercise on osteopenia and muscle atrophy in type 2 diabetes mellitus model rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192580/
https://www.ncbi.nlm.nih.gov/pubmed/30332436
http://dx.doi.org/10.1371/journal.pone.0204857
work_keys_str_mv AT akagawamanabu effectsofactivatedvitamindalfacalcidolandlowintensityaerobicexerciseonosteopeniaandmuscleatrophyintype2diabetesmellitusmodelrats
AT miyakoshinaohisa effectsofactivatedvitamindalfacalcidolandlowintensityaerobicexerciseonosteopeniaandmuscleatrophyintype2diabetesmellitusmodelrats
AT kasukawayuji effectsofactivatedvitamindalfacalcidolandlowintensityaerobicexerciseonosteopeniaandmuscleatrophyintype2diabetesmellitusmodelrats
AT onoyuichi effectsofactivatedvitamindalfacalcidolandlowintensityaerobicexerciseonosteopeniaandmuscleatrophyintype2diabetesmellitusmodelrats
AT yuasayusuke effectsofactivatedvitamindalfacalcidolandlowintensityaerobicexerciseonosteopeniaandmuscleatrophyintype2diabetesmellitusmodelrats
AT nagahataitsuki effectsofactivatedvitamindalfacalcidolandlowintensityaerobicexerciseonosteopeniaandmuscleatrophyintype2diabetesmellitusmodelrats
AT satochiaki effectsofactivatedvitamindalfacalcidolandlowintensityaerobicexerciseonosteopeniaandmuscleatrophyintype2diabetesmellitusmodelrats
AT tsuchiehiroyuki effectsofactivatedvitamindalfacalcidolandlowintensityaerobicexerciseonosteopeniaandmuscleatrophyintype2diabetesmellitusmodelrats
AT nagasawahiroyuki effectsofactivatedvitamindalfacalcidolandlowintensityaerobicexerciseonosteopeniaandmuscleatrophyintype2diabetesmellitusmodelrats
AT hongomichio effectsofactivatedvitamindalfacalcidolandlowintensityaerobicexerciseonosteopeniaandmuscleatrophyintype2diabetesmellitusmodelrats
AT shimadayoichi effectsofactivatedvitamindalfacalcidolandlowintensityaerobicexerciseonosteopeniaandmuscleatrophyintype2diabetesmellitusmodelrats